Yale Just Ran the Numbers on Anti-Aging. The Boring Stuff Won.
For most of my career, the honest answer to "Does this slow aging?" has been "Check back in about 30 years." That's how long it takes to count heart attacks, fractures and funerals. It's a lousy feedback loop. By the time the data shows up, the product has been rebranded twice and the influencer selling it has moved on to cold plunges.
A study published this month in Nature Medicine suggests that loop is getting shorter.
What the Yale team did
Raghav Sehgal and Albert Higgins-Chen at Yale School of Medicine gathered results from 51 clinical studies of anti-aging interventions. Instead of waiting for people to get sick, they compared biological age before and after each intervention using more than 110 DNA methylation biomarkers, including 16 of the best-known epigenetic clocks.
If you haven't met an epigenetic clock, think of it as an odometer on your DNA. Chemical tags called methyl groups attach to and drop off your genes in fairly predictable patterns as you age. Read enough of them and you can estimate how old your body is acting, which isn't always what your driver's license says.
What moved the needle
Lifestyle came through. Pairing regular exercise with a healthy eating plan consistently lowered epigenetic age. The diets ranged from Mediterranean to low-fat to low-carb, which should settle a few dinner-party arguments. The common thread wasn't the macros. It was eating well and moving, together.
Prescription drugs posted the biggest numbers. Metformin and semaglutide produced the strongest reductions. Anti-TNF therapies, which block an inflammatory protein, also showed benefit.
Over-the-counter supplements mostly flopped. As a group, they didn't produce meaningful reductions in biological age. Some medical procedures didn't register either.
One more detail deserves a spotlight. People living with disease showed bigger shifts than healthy participants. A drug that repairs a broken metabolism will naturally show more change than the same drug given to someone whose metabolism is humming along. It's easier to straighten a crooked picture than a straight one.
What it doesn't tell us
The researchers were refreshingly blunt about the limits, so I will be too.
We don't know whether these treatments directly caused the changes or whether something else came along for the ride. We don't know how fast the changes happen or whether they stick once treatment stops. And the big one: no one has shown that lowering your epigenetic age helps you live longer or stay healthier. Higgins-Chen framed it well. The real question is what the change means for long-term risk of disease and decline.
A younger clock is a promising signal. It isn't a longer life. Not yet.
Why this matters if you work in health
Here's the part that excites me. Newer clocks performed better than older ones. If these markers hold up as predictors of real outcomes, we could evaluate treatments in months instead of decades. That's a gift to clinicians, to researchers and, frankly, to consumers who are tired of paying for hope in a capsule.
It also raises the bar. Once biological age can be measured before and after, "clinically studied" on a label either starts to mean something or gets exposed. Companies in the longevity space should take note. Patients are going to start asking for receipts.
What I'm telling patients
Nothing radically new, which is sort of the point. After 35 years in women's health, I've watched trends arrive with fanfare and leave quietly. The interventions with the best evidence keep being the least glamorous ones: consistent movement and a real-food diet you can stick with. This analysis adds molecular evidence to some very old advice.
Metformin and semaglutide are serious medications with real indications. This study doesn't turn them into anti-aging pills for healthy people, and I'm not prescribing them that way. If you have prediabetes, diabetes or obesity, that's a conversation worth having with your doctor, and there's now one more interesting data point on the table.
As for the supplement aisle, read labels with healthy suspicion. If a product promises to reverse your biological age, ask to see the data. Odds are there isn't any. Or there is, and it says nothing happened.
The science of aging finally has a speedometer. Until it gets a crystal ball, I'll keep betting on the walk, the vegetables and the researchers honest enough to say "we don't know yet."
Reference: Sehgal R, Borrus D, Armstrong JF, et al. Responsiveness of epigenetic aging biomarkers to longevity interventions in humans. Nature Medicine. 2026;32(9):3477. doi:10.1038/s41591-026-04562-9











